19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Self management of patients with mild COPD in primary care: randomised controlled trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          To evaluate the effectiveness of telephone health coaching delivered by a nurse to support self management in a primary care population with mild symptoms of chronic obstructive pulmonary disease (COPD).

          Design

          Multicentre randomised controlled trial.

          Setting

          71 general practices in four areas of England.

          Participants

          577 patients with Medical Research Council dyspnoea scale scores of 1 or 2, recruited from primary care COPD registers with spirometry confirmed diagnosis. Patients were randomised to telephone health coaching (n=289) or usual care (n=288).

          Interventions

          Telephone health coaching intervention delivered by nurses, underpinned by Social Cognitive Theory. The coaching promoted accessing smoking cessation services, increasing physical activity, medication management, and action planning (4 sessions over 11 weeks; postal information at weeks 16 and 24). The nurses received two days of training. The usual care group received a leaflet about COPD.

          Main outcome measures

          The primary outcome was health related quality of life at 12 months using the short version of the St George’s Respiratory Questionnaire (SGRQ-C).

          Results

          The intervention was delivered with good fidelity: 86% of scheduled calls were delivered; 75% of patients received all four calls. 92% of patients were followed-up at six months and 89% at 12 months. There was no difference in SGRQ-C total score at 12 months (mean difference −1.3, 95% confidence interval −3.6 to 0.9, P=0.23). Compared with patients in the usual care group, at six months follow-up, the intervention group reported greater physical activity, more had received a care plan (44% v 30%), rescue packs of antibiotics (37% v 29%), and inhaler use technique check (68% v 55%).

          Conclusions

          A new telephone health coaching intervention to promote behaviour change in primary care patients with mild symptoms of dyspnoea did lead to changes in self management activities, but did not improve health related quality of life.

          Trial registration

          Current controlled trials ISRCTN 06710391

          Related collections

          Most cited references26

          • Record: found
          • Abstract: not found
          • Article: not found

          Self-management education: History, definition, outcomes, and mechanisms

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effect of a self-management program on patients with chronic disease.

            For patients with chronic disease, there is growing interest in "self-management" programs that emphasize the patients' central role in managing their illness. A recent randomized clinical trial demonstrated the potential of self-management to improve health status and reduce health care utilization in patients with chronic diseases. To evaluate outcomes of a chronic disease self-management program in a real-world" setting. Before-after cohort study. Of the 613 patients from various Kaiser Permanente hospitals and clinics recruited for the study, 489 had complete baseline and follow-up data. The Chronic Disease Self-Management Program is a 7-week, small-group intervention attended by people with different chronic conditions. It is taught largely by peer instructors from a highly structured manual. The program is based on self-efficacy theory and emphasizes problem solving, decision making, and confidence building. Health behavior, self-efficacy (confidence in ability to deal with health problems), health status, and health care utilization, assessed at baseline and at 12 months by self-administered questionnaires. At 1 year, participants in the program experienced statistically significant improvements in health behaviors (exercise, cognitive symptom management, and communication with physicians), self-efficacy, and health status (fatigue, shortness of breath, pain, role function, depression, and health distress) and had fewer visits to the emergency department (ED) (0.4 visits in the 6 months prior to baseline, compared with 0.3 in the 6 months prior to follow-up; P = 0.05). There were slightly fewer outpatient visits to physicians and fewer days in hospital, but the differences were not statistically significant. Results were of about the same magnitude as those observed in a previous randomized, controlled trial. Program costs were estimated to be about $200 per participant. We replicated the results of our previous clinical trial of a chronic disease self-management program in a "real-world" setting. One year after exposure to the program, most patients experienced statistically significant improvements in a variety of health outcomes and had fewer ED visits.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

              To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 second (FEV1) in smokers aged 35 to 60 years who have mild obstructive pulmonary disease. Randomized clinical trial. Participants randomized with equal probability to one of the following groups: (1) smoking intervention plus bronchodilator, (2) smoking intervention plus placebo, or (3) no intervention. Ten clinical centers in the United States and Canada. A total of 5887 male and female smokers, aged 35 to 60 years, with spirometric signs of early chronic obstructive pulmonary disease. Smoking intervention: intensive 12-session smoking cessation program combining behavior modification and use of nicotine gum, with continuing 5-year maintenance program to minimize relapse. Bronchodilator: ipratropium bromide prescribed three times daily (two puffs per time) from a metered-dose inhaler. Rate of change and cumulative change in FEV1 over a 5-year period. Participants in the two smoking intervention groups showed significantly smaller declines in FEV1 than did those in the control group. Most of this difference occurred during the first year following entry into the study and was attributable to smoking cessation, with those who achieved sustained smoking cessation experiencing the largest benefit. The small noncumulative benefit associated with use of the active bronchodilator vanished after the bronchodilator was discontinued at the end of the study. An aggressive smoking intervention program significantly reduces the age-related decline in FEV1 in middle-aged smokers with mild airways obstruction. Use of an inhaled anticholinergic bronchodilator results in a relatively small improvement in FEV1 that appears to be reversed after the drug is discontinued. Use of the bronchodilator did not influence the long-term decline of FEV1.
                Bookmark

                Author and article information

                Contributors
                Role: professor
                Role: lecturer
                Role: statistician
                Role: senior lecturer
                Role: professor
                Role: reader
                Role: professor
                Role: professor
                Role: senior statistician
                Role: professor
                Role: reader
                Role: lecturer
                Role: senior research fellow
                Role: trial coordinator
                Role: consultant
                Role: professor
                Journal
                BMJ
                BMJ
                BMJ-UK
                bmj
                The BMJ
                BMJ Publishing Group Ltd.
                0959-8138
                1756-1833
                2018
                13 June 2018
                : 361
                : k2241
                Affiliations
                [1 ]Institute of Applied Health Research, Murray Learning Centre, University of Birmingham, Birmingham, B15 2ER, UK
                [2 ]Department of Health Sciences, University of Leicester, Leicester, UK
                [3 ]Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK
                [4 ]Department of Health Sciences, University of York, York, UK
                [5 ]School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK
                [6 ]Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
                [7 ]Centre for Exercise and Rehabilitation Science, Biomedical Research Centre (Respiratory), University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester UK
                [8 ]Research Institute for Primary Care and Health Sciences, Keele University, Keele, UK
                [9 ]School of Education Research, University of Birmingham, Birmingham, UK
                [10 ]Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, UK
                [11 ]Warwick Primary Care, University of Warwick, Warwick, UK
                Author notes
                Correspondence to: K Jolly c.b.jolly@ 123456bham.ac.uk
                Article
                jolk042829
                10.1136/bmj.k2241
                5998171
                29899047
                91712a45-da26-4eb0-aa59-cdaaab10a039
                Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

                This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.

                History
                : 17 April 2018
                Categories
                Research
                508

                Medicine
                Medicine

                Comments

                Comment on this article